# A concentrated portfolio helps Baylor focus capital and time

Markdown copy of https://realalpha.app/s/a-concentrated-portfolio-helps-baylor-focus-capital-and-time/ on Real Alpha, the best minutes from long interviews with the people building AI. Cite and link the page, not this copy.

- Speaker: [Renee Hanna](https://realalpha.app/people/renee-hanna/) · Renee Hanna is a Managing Director of Investments at Baylor University. · Oversees Baylor’s private investments across categories and geographies, bringing nearly two decades of endowment experience.
- Host: [David Weisburd](https://realalpha.app/people/david-weisburd/)
- Show: How I Invest
- Episode: [Baylor Endowment on Rethinking Venture Capital, Concentrated Portfolios, and Power of Compounding](https://realalpha.app/v/e-OELl_818g/), Nov 16, 2026
- Moment: 13:24 to 19:46 of the episode (6 min), playing on https://realalpha.app/s/a-concentrated-portfolio-helps-baylor-focus-capital-and-time/; the episode from there: https://realalpha.app/v/e-OELl_818g/?t=804

## Quote

> “Today, it's closer to two fifty, so **approximately 25% of the overall portfolio**.”
> — [Renee Hanna](https://realalpha.app/people/renee-hanna/) at [16:28](https://realalpha.app/v/e-OELl_818g/?t=988) · How I Invest

## Takeaways

1. Baylor increased capital in its top 20 private names to about $250 million.
2. The team deploys $160 million a year and typically adds one GP.
3. Meetings and relationships are chosen to fit portfolio priorities.

## About this segment

Renee Hanna describes why Baylor limits its GP relationships, grows commitments to trusted managers and targets portfolio gaps. Fewer relationships make it easier to focus capital and spend time where it matters.

From “Baylor Endowment on Rethinking Venture Capital, Concentrated Portfolios, and Power of Compounding”, Nov 16, 2026. [Watch the full episode](https://realalpha.app/v/e-OELl_818g/)

## Transcript

From the transcript How I Invest publishes with the episode.

[13:37](https://realalpha.app/v/e-OELl_818g/?t=817) So, at Baylor, one of our alpha drivers, that we see is concentration. We're really trying to construct a portfolio with fewer line items. Historically, I think we've been overly diversified, it was really just a race to the middle. So, to the extent that we can get access to some of these larger platforms, I think we would have a better shot at it today. But I do not think we'd be able to size it in a way that would give us the exposure that we need.

[14:02](https://realalpha.app/v/e-OELl_818g/?t=842) People often talk about this saying that the fund size is a strategy for a GP, but it also seems to be the strategy for the LP as well. Absolutely. I mean, we're trying to construct a portfolio. If I can get into a great name and it's only a $5,000,000 check size on a $2,700,000,000 endowment, I'm not sure that I care, right? It doesn't move the needle. And we are also operating with a lean team. We've got three people on the private team, three people on the marketable team, three people on the ops team.

[14:29](https://realalpha.app/v/e-OELl_818g/?t=869) Every time you add a new line item, you're effectively, like, increasing the workload for everybody else. And so you want it to count. What are some other, I guess, second order effects of just having too many names? You get spread too thin in terms of travel. We work really hard to be on the L PAC, and not because we need that board seat. It's more about the relationship. We've seen that when you're on the L PAC, you have a tighter relationship with the GP.

[14:52](https://realalpha.app/v/e-OELl_818g/?t=892) It tends to be more collaborative. We want to have that give and take. And with that, you necessarily need to spend time with the GP. You need to show up to the annual meeting. You need to be there in person. And that's not scalable. There's only so much of you to go around in a three sixty five day calendar and still give yourself time to actually think about portfolio construction and what your next step should be.

[15:11](https://realalpha.app/v/e-OELl_818g/?t=911) The return on time is probably the most critical piece that we think about as we bring in a new line item. It's Upstream of these relationships are, going back to earlier conversation, is these direct investments, these co investments that are so critical to your returns. Oftentimes, talk about Dunbar's law, which is you can only really manage a 150 close relationships. And people will argue until they're blue in the face, but the podcast is actually one of the only hacks that I've seen in terms of increasing Del Mar's Law where you could build this relationship and and keep up these relationships.

[15:38](https://realalpha.app/v/e-OELl_818g/?t=938) But Mhmm. It's so hard to have too many close relationships. Even though people hate this idea, they hate being boxed in to this 150 relationships in practice, it's it's pretty consistent with what I've seen. I'm impressed if somebody can manage a 150. We have 20 names in our book that matter. And what other strategic benefits out of these 20 names in terms of... On on top of direct investments, what other strategic value do you get from your managers?

[16:04](https://realalpha.app/v/e-OELl_818g/?t=964) We are purposefully keeping our book tight and refined in terms of the number of GPs that we can commit to. And one of them is because of scale. We really want to lean into our top relationships. And so we're seeing commitments go from $20,000,000 in fund two to $40,000,000 in the subsequent fund. As we gain conviction in a GP, we really want to put our money behind that and back them. And it also allows us to have a more concentrated portfolio.

[16:30](https://realalpha.app/v/e-OELl_818g/?t=990) We've worked really hard to get more capital into our top 20 names If you rolled it back, say, even five years ago, it was closer to $100,000,000 in our top 20 private names. Today, it's closer to two fifty, so approximately 25% of the overall portfolio. And when you look at the 1,300 line items of portfolio companies across the book, 80% is in the top 300. It took some work to get there, but it's by design.

[16:56](https://realalpha.app/v/e-OELl_818g/?t=1016) We don't necessarily have an approach where we have to be in the top GP of that vintage for that strategy. Let's find somebody we can find a partnership with. Let's find somebody who's really, really good at executing in this space. And then let's back them with the full force of Baylor behind it and continue to back them for several funds. You know, obviously they need to hold up their end of the bargain and continue to perform well, but we're not gonna jump ship just because you were top quartile and not top decile of that particular year because we're gonna believe in your ability to execute over time.

[17:26](https://realalpha.app/v/e-OELl_818g/?t=1046) Roger Vinson, who was formerly at Cornell Endowment, he talked about he believed the systematic error most LPs are making is they're overly diversified. They have a portfolio of companies within the manager, then they have 20 managers or 40 managers, and they have... Sometimes they even have diversification on that, vintage diversification. Yep. And at some point, you're essentially just getting the market.

[17:46](https://realalpha.app/v/e-OELl_818g/?t=1066) Right. And you're you're basically defeating the entire purpose of being an active investor. Mhmm. Couldn't agree more. So we make really tough decisions. We have a finite budget of $160,000,000 that we're deploying in a given calendar year. And we typically have capacity to add one new GP to the portfolio. And so, we're very thoughtful about our portfolio framework. Where are we under allocated? Today, we're underweight healthcare, so we're spending a lot of time market mapping and what does our next move look like?

[18:13](https://realalpha.app/v/e-OELl_818g/?t=1093) Is it going to be an early stage commitment versus lower middle market buyout? Where's the best place to put capital to work? And then we take meetings that fit in that lane. We don't take meetings across the board in categories that aren't a high priority for us. Again, going back to our return on time, we're very thoughtful about how we spend our time when we're in the office and the pipeline that we're building based on the capital budget that we're trying to fill.

[18:38](https://realalpha.app/v/e-OELl_818g/?t=1118) I love that because the mere fact that you even know where the holes in the portfolio are is upstream of being able to have these strategic calls, which is upstream of that is having a concentrated portfolio. Mhmm. So a lot of people, it's hard for them to envision, well, what would I do with extra time? Well, you don't envision it because you don't even have the time to think about things. So kind of having a concentrated portfolio could also open you up to having time to focus strategically.

[19:03](https://realalpha.app/v/e-OELl_818g/?t=1143) A lot of people will be like, We have an open door policy. We take meetings, and there's lots of learnings that come from that. And I think early on in your career, when you're an analyst and you're trying to flex that muscle and get pattern recognition, I can understand how that would make sense. But over time for us, we felt like we just aren't having enough time to think. And candidly, as a GP, that's a waste of your time as well, right?

[19:22](https://realalpha.app/v/e-OELl_818g/?t=1162) If I know that I'm taking a meeting in private credit and we do not invest in private credit, like why do you want to sit down with me? There's much better places to spend your time, and I'm happy to make introductions to the groups who I know really like that flavor of investing.
